Inflammatory Bowel Disease (IBD)
Today, Mount Sinai digestive disease specialists care for more patients with inflammatory bowel disease (IBD) than any other medical center in the country. Digestive disease specialists from throughout the New York tri-state area send their most challenging cases to our IBD physicians.
For nearly 80 years, we have been at the forefront of research and treatment for ulcerative colitis and Crohn’s disease — the two most common forms of IBD. In fact, Crohn’s disease was named for Mount Sinai physician Burrill B. Crohn, MD, after he and his colleagues first described the condition in 1932.
Because IBD influences so many aspects of life and may affect other organs, your care will involve a close-knit team of experts. To obtain the best diagnostic results, we use the most advanced technologies. For example, we are applying a new technique using dye-spray, together with more sensitive light sources, to detect early lesions in patients with long-standing ulcerative colitis. We then biopsy these lesions, increasing the chances of identifying and even preventing early cancers.
Mount Sinai IBD specialists are constantly conducting clinical trials to develop or test advanced treatments. Patients eligible for these studies might receive potentially groundbreaking new therapies and medications before they are available anywhere else in the world.
To learn more about Mount Sinai’s IBD diagnostic and treatment services, please visit:
The Mount Sinai Health System
1425 Madison Avenue
New York, NY 10029